On January 2, 20X1, Xerxes Corporation ('XC') acquired a U.S. patent from Queen's University's Faculty of Computer Engineering for $170,000. The patent had an original life of 17 years, but 'sat on the shelf' for the first 3 years until purchased by XC. XC's management forecasts that it will be able to generate sales from products based this patent's technology starting immediately and continuing for approximately 8 years before anticipated new R&D by competitors renders this technology obsolete. XC has an April 30 year-end. Considering all reasonable accounting policy alternatives, what is the minimum amount that XC could charge to amortization expense in respect of the patent for its 20X1 fiscal year? $0 $3,333 $4,048 O $5,312 O$7,083